Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 28 of 41
Neurobiological Bases of Placebo Response in Major Depressive Disorder
NCT01787240
Evaluation of PET/MRI in Children With Cancer
NCT01839747
Implementation of CPT for PTSD in Diverse Communities
NCT01702168
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
NCT01793753
Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
NCT01706913
Symptom Tracking in Assisted Reproductive Technologies
NCT01746797
Cross-Sectional Iloperidone IVGTT
NCT01686815
Prevention of Delirium After Bone Marrow Transplantation
NCT01700816
Molecular and Functional PET-fMRI Measures of Analgesia in Migraine
NCT01970943
Implementation of ACT Through Facebook for Teenagers With Asthma
NCT01675921
Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep
NCT01485380
Lenalidomide Plus Chemotherapy for AML
NCT01681537
The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease
NCT01709669
Building on a Point-of-purchase Intervention to Encourage Healthy Food Choices
NCT01604499
The Effect of Calorie Deprivation on Adipose Tissue Distribution
NCT01658397
Lidocaine Serum Levels in Healthy Adult Volunteers: a Pilot Evaluation of the J-Tip Delivery System
NCT01674075
Efficacy Study of a Novel Device to Clean the Endotracheal Tube
NCT01765530
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
NCT01673594
Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis
NCT01441271
Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study
NCT01665989
Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery
NCT02063035
Educational Intervention to Reduce Outpatient Inappropriate Transthoracic Echocardiograms
NCT01944202
Simvastatin Augmentation of Lithium Treatment in Bipolar Depression
NCT01665950
Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study
NCT01927887
Optional Follow-up Visits for Common, Low-risk Arm Fractures
NCT01583556
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
NCT01643668
A Modernized Approach to Prenatal Care in Low Risk Women
NCT01606774
Normobaric Oxygen (NBO) Therapy in Acute Migraine
NCT01542307
Effects of Eszopiclone on Sleep and Memory in Schizophrenia
NCT01641900
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
NCT01534897
Brentuximab Vedotin for Steroid Refractory GvHD
NCT01596218
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
NCT01611675
Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery
NCT01588158
Cabozantinib in Advanced Solid Malignancies
NCT01588821
Audio-enhanced Analgesia in Healthy Subjects
NCT01835275
Understanding "Heparin Resistance" in Cardiac Surgery
NCT01598883
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
NCT01582295
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
NCT01642043
Text to Move (TTM)Study
NCT01569243
The Neurobiology of Expectancy and Pain Perception
NCT01575106
Nasal Mask Ventilation During the Induction of General Anesthesia
NCT01651286
Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease
NCT01742182
Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
NCT01615367
Imaging Study of the Lungs During an Allergic Asthma Attack
NCT01547286
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
NCT01533493
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
NCT01583543
Therapy for Undergraduate College Students Who Binge Drink and Are Depressed
NCT01632319
Effects of Acipimox on Mitochondrial Function in Obesity
NCT01488409
External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks
NCT01581619
The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
NCT01586897
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.